These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2119959)

  • 1. Clinical trial with somatonorm in idiopathic growth hormone deficiency in children.
    Shi YF; Liu R; Bao XL; Deng JY; Gunnarsson R
    Chin Med J (Engl); 1990 Jun; 103(6):470-7. PubMed ID: 2119959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of second somatonorm treatment in idiopathic growth hormone deficiency dwarfism].
    Bao X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Dec; 13(6):443-6. PubMed ID: 1838961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth and growth hormone therapy in children with achondroplasia: a two-year experience.
    Stamoyannou L; Karachaliou F; Neou P; Papataxiarchou K; Pistevos G; Bartsocas CS
    Am J Med Genet; 1997 Oct; 72(1):71-6. PubMed ID: 9295079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of the treatment of growth hormone deficiency with methionine-somatotropin or recombinant somatotropin].
    Dorantes-Alvarez LM
    Bol Med Hosp Infant Mex; 1990 Jun; 47(6):369-71. PubMed ID: 2222818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
    Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and biochemical evaluation of the administration of growth hormone].
    Mendoza-Morfin F; Cárdenas-Tirado H
    Bol Med Hosp Infant Mex; 1990 Aug; 47(8):551-6. PubMed ID: 2257092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prader-Labhart-Willi syndrome: auxological response to a conventional dose of growth hormone in patients with classical growth hormone deficiency.
    Schmidt H; Bechtold S; Schwarz HP
    Eur J Med Res; 2000 Jul; 5(7):307-10. PubMed ID: 10903191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum leptin and IGF-I during growth hormone treatment in chronic renal failure.
    Patel L; Webb NJ; Bradbury MG; Zaman N; Smith P; Lewis MA; Postlethwaite RJ; Price DA; Clayton PE
    Pediatr Nephrol; 2002 Aug; 17(8):643-7. PubMed ID: 12185474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human growth hormone therapy of non-growth hormone deficient children.
    Ranke MB
    Pediatrician; 1987; 14(3):178-82. PubMed ID: 3331012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Authentic recombinant human growth hormone. Results of a multicenter clinical trial in patients with growth hormone deficiency.
    Rasmussen LH; Zachmann M; Nilsson P
    Helv Paediatr Acta; 1989 Jun; 43(5-6):443-8. PubMed ID: 2663792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of pituitary dwarfism with recombinant human growth hormone. A multicenter study].
    Bierich JR; Ranke MB; Beyer P; Bittner P; Borkenstein H; Brämswig J; Butenandt O; Kollmann F; Stöver B; Schweikert HU
    Dtsch Med Wochenschr; 1986 Mar; 111(13):483-9. PubMed ID: 3514193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with Somatonorm.
    Girard F; Gourmelen M
    Acta Paediatr Scand Suppl; 1986; 325():29-32. PubMed ID: 3296637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary human growth hormone measurement using a highly sensitive sandwich enzyme immunoassay: diagnostic and therapeutic uses in patients with growth hormone deficiency.
    Kohno H; Murakami Y; Kodaira T
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1496-500. PubMed ID: 2229307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of subcutaneous and intramuscular administration of human growth hormone in the therapy of growth hormone deficiency.
    Russo L; Moore WV
    J Clin Endocrinol Metab; 1982 Nov; 55(5):1003-6. PubMed ID: 6889608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience of somatrem: UK preliminary report.
    Milner RD
    Acta Paediatr Scand Suppl; 1986; 325():25-8. PubMed ID: 3296636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case report of growth attenuation during methionyl human growth hormone treatment.
    Okada Y; Taira K; Takano K; Hizuka N
    Endocrinol Jpn; 1987 Aug; 34(4):621-6. PubMed ID: 3678156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pituitary dwarfism with biosynthetic growth hormone.
    Bierich JR
    Acta Paediatr Scand Suppl; 1986; 325():13-8. PubMed ID: 3296634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of pituitary dwarfism with methionyl human growth hormone in Japan.
    Takano K; Shizume K; Hizuka N; Okuno A; Umino T; Kobayashi Y; Kusano S; Nakajima H; Irie M; Hibi I
    Endocrinol Jpn; 1986 Oct; 33(5):589-96. PubMed ID: 3830068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with somatrem in growth hormone deficiency.
    Vicens-Calvet E; Potau N; Carracosa A; Albisu M; Gusiñer M; Cuatrecasas JM; Strindberg B; Flodh H
    Acta Paediatr Scand Suppl; 1986; 325():33-40. PubMed ID: 3296638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal administration of human growth hormone (hGH) in combination with a membrane permeation enhancer in patients with GH deficiency: a pharmacokinetic study.
    Hedin L; Olsson B; Diczfalusy M; Flyg C; Petersson AS; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1993 Apr; 76(4):962-7. PubMed ID: 8473411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.